Gaucher's Disease Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Clinical Trials

A Clinical Trial of PR001 (LY3884961) in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED)
Condition:   Gaucher Disease Interventions:   Biological: LY3884961;   Drug: Methylprednisolone;   Drug: Sirolimus;   Drug: Prednisone Sponsors:   Prevail Therapeutics;   Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 4, 2022 Category: Research Source Type: clinical trials